Michael Doherty

Investor

Entrepreneur in Residence (EIR) at DigitalDx Ventures

About

Michael Doherty is a pharmaceutical and diagnostics executive focused on precision medicine, with deep expertise in regulatory affairs and product development. He formerly served as Global Head of Pharma Regulatory Affairs at Roche/Genentech and helped secure approval of Foundation Medicine's F1CDx NGS panel; he now holds board and advisory roles at several life sciences companies.